MA
LLY icon

MCF Advisors’s Eli Lilly LLY Stock Holding History

MCF Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.24M Buy
3,526
+761
+28% +$772K 0.14% 81
2025
Q4 		$2.97M Buy
2,765
+270
+11% +$258K 0.16% 66
2025
Q3 		$1.9M Sell
2,495
-396
-14% -$295K 0.12% 66
2025
Q2 		$2.25M Buy
2,891
+419
+17% +$326K 0.15% 52
2025
Q1 		$2.04M Sell
2,472
-69
-3% -$57.4K 0.15% 53
2024
Q4 		$1.96M Sell
2,541
-309
-11% -$256K 0.14% 53
2024
Q3 		$2.52M Buy
2,850
+2
+0.1% +$1.8K 0.18% 46
2024
Q2 		$2.58M Sell
2,848
-7
-0.2% -$5.6K 0.2% 42
2024
Q1 		$2.22M Buy
2,855
+145
+5% +$103K 0.17% 49
2023
Q4 		$1.58M Buy
2,710
+38
+1% +$22.2K 0.13% 57
2023
Q3 		$1.43M Sell
2,672
-182
-6% -$93.8K 0.13% 58
2023
Q2 		$1.34M Buy
2,854
+389
+16% +$163K 0.12% 56
2023
Q1 		$846K Buy
2,465
+40
+2% +$13.5K 0.08% 81
2022
Q4 		$887K Hold
2,425
– – 0.09% 77
2022
Q3 		$784K Hold
2,425
– – 0.09% 76
2022
Q2 		$786K Buy
2,425
+191
+9% +$57.3K 0.08% 69
2022
Q1 		$640K Buy
+2,234
New +$575K 0.06% 95
2021
Q4 		– Sell
-2,234
Closed -$516K – 407
2021
Q3 		$516K Buy
2,234
+46
+2% +$11.4K 0.05% 99
2021
Q2 		$502K Hold
2,188
– – 0.05% 92
2021
Q1 		$409K Hold
2,188
– – 0.05% 97
2020
Q4 		$369K Hold
2,188
– – 0.04% 96
2020
Q3 		$324K Hold
2,188
– – 0.04% 103
2020
Q2 		$359K Sell
2,188
-1,231
-36% -$189K 0.05% 96
2020
Q1 		$474K Hold
3,419
– – 0.08% 70
2019
Q4 		$449K Hold
3,419
– – 0.07% 87
2019
Q3 		$382K Buy
3,419
+127
+4% +$14.1K 0.06% 98
2019
Q2 		$365K Hold
3,292
– – 0.06% 94
2019
Q1 		$427K Sell
3,292
-475
-13% -$57.8K 0.07% 83
2018
Q4 		$436K Buy
3,767
+2
+0.1% +$223 0.08% 78
2018
Q3 		$404K Buy
3,765
+3
+0.1% +$300 0.07% 82
2018
Q2 		$321K Buy
3,762
+3
+0.1% +$246 0.06% 95
2018
Q1 		$291K Buy
3,759
+12
+0.3% +$966 0.06% 92
2017
Q4 		$316K Buy
3,747
+14
+0.4% +$1.19K 0.06% 86
2017
Q3 		$319K Buy
3,733
+15
+0.4% +$1.23K 0.06% 83
2017
Q2 		$306K Sell
3,718
-185
-5% -$15.1K 0.06% 77
2017
Q1 		$328K Buy
3,903
+214
+6% +$17.1K 0.07% 71
2016
Q4 		$271K Buy
3,689
+17
+0.5% +$1.27K 0.06% 73
2016
Q3 		$295K Sell
3,672
-390
-10% -$31.2K 0.07% 73
2016
Q2 		$320K Buy
4,062
+144
+4% +$10.8K 0.08% 73
2016
Q1 		$282K Buy
3,918
+17
+0.4% +$1.29K 0.07% 69
2015
Q4 		$329K Sell
3,901
-62
-2% -$5.14K 0.09% 63
2015
Q3 		$332K Buy
3,963
+15
+0.4% +$1.27K 0.09% 60
2015
Q2 		$330K Buy
3,948
+14
+0.4% +$1.07K 0.08% 58
2015
Q1 		$286K Buy
3,934
+18
+0.5% +$1.28K 0.07% 65
2014
Q4 		$270K Sell
3,916
-275
-7% -$18.6K 0.07% 68
2014
Q3 		$247K Buy
4,191
+20
+0.5% +$1.27K 0.07% 72
2014
Q2 		$246K Sell
4,171
-11
-0.3% -$656 0.08% 71
2014
Q1 		$246K Buy
4,182
+1,002
+32% +$55.9K 0.08% 70
2013
Q4 		$187K Sell
3,180
-75
-2% -$3.76K 0.07% 87
2013
Q3 		$192K Buy
3,255
+192
+6% +$10.1K 0.11% 79
2013
Q2 		$180K Buy
+3,063
New +$167K 0.11% 76

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MCF Advisors's LLY Position: Q1 2026 in Review

MCF Advisors increased its Eli Lilly (LLY) stake by 28% in Q1 2026, buying an estimated $772K and bringing the position to 3,526 shares worth $3.24M. The position accounts for 0.14% of the portfolio, ranked #81.

MCF Advisors first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • MCF Advisors held 3,526 shares of Eli Lilly worth $3.24M as of Q1 2026.
  • MCF Advisors bought 761 Eli Lilly shares in Q1 2026, an estimated $772K.
  • Eli Lilly made up 0.14% of MCF Advisors's portfolio in Q1 2026, its #81 holding.
  • MCF Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.